Our studies identify a novel crosstalk between TGFβ and IGF-1R signaling through the adaptor protein, IRS-1, indicating that one of the mechanisms by which TGFβ elicits its tumor suppressor function is through inhibition of IRS-1 expression and activation in colon cancer cells. The gene discussed is IRS1; the disease is malignant colon neoplasm.